2',3'-Dideoxycytidine cytotoxicity in human macrophages.
Human macrophages when cultured for several weeks in the presence of therapeutically relevant 2',3'-dideoxycytidine (ddC) concentrations show a time-dependent decay in mitochondrial DNA content. This decay is associated with a reduction of Rhodamine 123 fluorescence, a marker for mitochondrial membrane potential suggesting that impairment of mitochondrial functions occurs. Mitochondrial metabolic impairment was confirmed by direct evaluation of lactate production, which is markedly increased in cells treated with ddC. The activity of protein kinase C and intracellular free Ca2+ upon addition of phorbol 12-myristate 13-acetate (PMA) were lower in the drug-treated cells compared to controls. A 50% reduction in O2-release was also found upon PMA stimulation. Fluorescent latex beads, yeast and bacteria phagocytosis were normal, but intracellular bacteria killing was markedly impaired in ddC-exposed macrophages. Thus, ddC exerts a delayed mitochondrial toxicity also on differentiated macrophages with impairment of several metabolic properties and O2 production causing a reduced ability of these phagocytic cells to kill phagocytosed bacteria.
Antonelli
A
A
Institute of Biochemistry G. Fornaini, University of Urbino, Italy.
Brandi
G
G
Casabianca
A
A
Magnani
M
M
D019380:Anti-HIV Agents / Q000633:toxicity*; D002478:Cells, Cultured; D004272:DNA, Mitochondrial / Q000032:analysis; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000502:physiology; D008856:Microscopy, Fluorescence; D010587:Phagocytosis / Q000187:drug effects*; D020112:Rhodamine 123; D012235:Rhodamines; D013481:Superoxides / Q000378:metabolism; D016047:Zalcitabine / Q000633:toxicity*
D019380:Anti-HIV Agents; D004272:DNA, Mitochondrial; D012235:Rhodamines; D013481:Superoxides; D020112:Rhodamine 123; D016047:Zalcitabine